Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00610355 in moderate asthma
NCT00830427Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Apr 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of PF-00610355 in asthma, sponsored by Pfizer. Planned start Apr 2009; status: withdrawn.
02
Drugs
PF-00610355
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00830427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830427.